Classification Information
Pharmaceutical product, namely, radiolabelled pharmaceutical preparations that target neuroendocrine tumor cell surface receptors for the detection and localization of neuroendocrine tumors in cancer patients and for targeted diagnostic management of the neuroendocrine tumors in cancer patients
Pharmaceuticals